- Investing Ideas
- Indian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Indian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
4
0 new
High return on equity, past performance and sound balance sheet.
4 companies
Procter & Gamble Health
Market Cap: ₹111.6b
Manufactures and markets pharmaceuticals and chemical products in India and internationally.
500126
₹6,723.60
7D
-1.1%
1Y
15.3%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹425.8b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,513.25
7D
2.4%
1Y
-20.3%
Abbott India
Market Cap: ₹595.1b
Operates as a pharmaceutical company in India.
500488
₹28,003.45
7D
-0.04%
1Y
-17.1%
Acutaas Chemicals
Market Cap: ₹266.9b
Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.
ACUTAAS
₹3,259.50
7D
-9.9%
1Y
181.4%